(Q48721210)

14 February 2018

title

Psychiatric side effects and fluctuations in serotonergic parameters in the treatment of chronic hepatitis C infection (English)

1 reference

14 February 2018

1 reference

5

1 reference

14 February 2018

author name string

G Bezemer

1

1 reference

14 February 2018

A R Van Gool

2

1 reference

14 February 2018

D Fekkes

3

1 reference

14 February 2018

J M Vrolijk

4

1 reference

14 February 2018

H L A Janssen

6

1 reference

14 February 2018

R J de Knegt

7

1 reference

14 February 2018

publication date

24 February 2012

1 reference

14 February 2018

published in

Neuropsychobiology

1 reference

14 February 2018

volume

65

1 reference

14 February 2018

issue

3

1 reference

14 February 2018

page(s)

126-132

1 reference

14 February 2018

Hepatitis C virus infection

cites work

1 reference

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

21 January 2018

1 reference

Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study

21 January 2018

1 reference

Neuropsychiatric side effects of interferon-alfa therapy

21 January 2018

1 reference

Cytokines and major depression

21 January 2018

1 reference

Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system

21 January 2018

1 reference

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

21 January 2018

1 reference

Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients

21 January 2018

1 reference

Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.

21 January 2018

1 reference

Ribavirin inhibits angiogenesis by tetrahydrobiopterin depletion.

21 January 2018

1 reference

Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression.

21 January 2018

1 reference

Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression

21 January 2018

1 reference

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

21 January 2018

1 reference

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.

21 January 2018

1 reference

Hypotension caused by extracorporeal circulation: serotonin from pump-activated platelets triggers nitric oxide release

21 January 2018

1 reference

Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients.

21 January 2018

1 reference

Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations

21 January 2018

1 reference

Hepatitis-C patients have reduced growth hormone (GH) secretion which improves during long-term therapy with pegylated interferon-alpha

21 January 2018

1 reference

Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen deficiency or depression?

21 January 2018

1 reference

Alterations of seminal and hormonal parameters: An extrahepatic manifestation of HCV infection?

21 January 2018

1 reference

Psychiatric disorders among veterans with hepatitis C infection

21 January 2018

1 reference

Hepatitis C and Depressive Symptoms: Psychological and Social Factors Matter More Than Liver Injury

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000330585

1 reference

14 February 2018

1 reference

14 February 2018